Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: A prospective study

Acta Pharmacologica Sinica

Volumn 32, Issue 8, 2011, Pages 1063-1070

  Di Carlo, Paola ^a   Romano, Amelia ^b   Casuccio, Alessandra ^a   Cillino, Salvatore ^a   Schimmenti, Maria Gabriella ^b   Mancuso, Giorgio ^c   La Chiusa, Stella ^c   Novara, Vincenzo ^b   Ingrassia, Daniela ^a   Li Vecchi, Valentina ^a   Trizzino, Marcello ^a   Titone, Lucina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ospedale dei Bambini G Di Cristina   (Italy)

^c Buccheri La Ferla Hospital   (Italy)

Author keywords

congenital infection; neurological prognosis; ocular prognosis; prenatal screening; serological response; Toxoplasma gondii; Western blot analysis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PYRIMETHAMINE; SULFADIAZINE;

AMNIOCENTESIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL INFECTION; DEVELOPMENTAL STAGE; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HEARING TEST; HUMAN; IMMUNOBLOTTING; NEUROLOGIC EXAMINATION; NEWBORN DISEASE; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRESCHOOL CHILD; PROGENY; PROGNOSIS; PROSPECTIVE STUDY; SEROCONVERSION; SPONTANEOUS ABORTION; TOXOPLASMOSIS; VERTICAL TRANSMISSION; VISUAL SYSTEM EXAMINATION; WESTERN BLOTTING;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; TOXOPLASMOSIS, CONGENITAL;

EID: 80051531723     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.55     Document Type: Article

References (37)

1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-76. (Pubitemid 38759657)
2. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Infectious Diseases of the Fetus and Newborn Infant, 6th edn. Editors: Remington JS, Klein JO, Wilson CB, Baker CJ. Philadelphia, PA: Elsevier-Saunders; 2006. p948-1091.
3. Embleton. The Northern Region's Perinatal Mortality Survey. Fetal and neonatal death from maternally acquired infection. Paediatr Perinat Epidemiol 2001; 15: 54-60.
4. Sterkers Y, Varlet-Marie E, Marty P, Bastien P, on behalf of the ANOFEL Toxoplasma-PCR Quality Control Group. Diversity and evolution of methods and practices for the molecular diagnosis of congenital toxoplasmosis in France: A four years survey. Clin Microbiol Infect Clin Microbiol Infect 2010; 16: 1594-602
5. Maudry A, Chene G, Chatelain R, Patural H, Bellete B, Tisseur B, et al. Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clin Vaccine Immunol 2009; 16: 1322-6.
6. Lago EG, Neto EC, Melamed J, Rucks AP, Presotto C, Coelho JC, et al. Congenital toxoplasmosis: Late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatr Perinat Epidemiol 2007; 21: 525-31. (Pubitemid 47609684)
7. Bénard A, Petersen E, Salamon R, Chěne G, Gilbert R, Salmi LR, et al. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill 2008; 13. pii: 18834.
8. Röser D, Nielsen HV, Petersen E, Saugmann-Jensen P, Nørgaard- Pedersen PB. Congenital toxoplasmosis-a report on the Danish neonatal screening programme 1999-2007. J Inherit Metab Dis 2010; 33: S241-247.
9. Berrébi A, Assouline C, Bessiéres MH, Lathiére M, Cassaing S, Minville V, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 2010; 203: 552.e1-6.
10. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004; 113: 1567-72. (Pubitemid 38697960)
11. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996; 15: 799-805. (Pubitemid 26386122)
12. Tridapalli E, Capretti M, Farneti G, Marangoni A, Cevenini R, Faldella G. Congenital toxoplasmosis: The importance of the Western blot method to avoid unnecessary therapy in potentially infected newborns. Acta Paediatr 2008; 97: 1298-300.
13. Di Carlo P, Casuccio A, La Chiusa S, Mazzola A, Pampinella D, Romano A, et al. Diagnosis of congenital toxoplasmosis: Pre- and post-natal evaluation in Sicilian (Italy) epidemiological area. Preliminary data. Parassitologia 2007; 49: 39-41.
14. Cassaing S, Bessiéres MH, Berry A, Berrebi A, Fabre R, Magnaval JF. Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR. J Clin Microbiol 2006; 44: 720-4.
15. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: An observational prospective cohort study. PLoS Med 2010; 7. pii: E1000351.
16. Vesco G, Buffolano W, La Chiusa S, Mancuso G, Caracappa S, Chianca A, et al. Toxoplasma gondii infections in sheep in Sicily, southern Italy. Vet Parasitol 2007; 146: 3-8. (Pubitemid 46550720)
17. Berrebi A, Bardou M, Bessieres MH, Nowakowska D, Castagno R, Rolland M, et al. Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: A study of 36 cases. Eur J Obstet Gynecol Reprod Biol 2007; 135: 53-7. (Pubitemid 350026157)
18. SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiebaut R, Leproust S, Chene G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: A meta-analysis of individual patients' data. Lancet 2007; 369: 115-22.
19. Garcia-Méric P, Franck J, Dumon H, Piarroux R. Management of congenital toxoplasmosis in France: Current data. Presse Med 2010; 39: 530-8.
20. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008; 47: 554-66.
21. Gay-Andrieu F, Marty P, Pialat J, Sournies G, Drier de Laforte T, Peyron F. Fetal toxoplasmosis and negative amniocentesis: Necessity of an ultrasound follow-up. Prenat Diagn 2003; 23: 558-60. (Pubitemid 36917375)
22. Villena I, Bory JP, Chemla C, Hornoy P, Pinon JM. Congenital toxoplasmosis: Necessity of clinical and ultrasound follow-up despite negative amniocentesis. Prenat Diagn 2003; 23: 1098-9. (Pubitemid 38084156)
23. Herman-Sucharska I, Bekiesinska-Figatowska M, Urbanik A. Fetalcentral nervous system malformations on MR images. Brain Dev 2009; 31: 185-99.
24. Freeman K, Tan HK, Prusa A, Petersen E, Buffolano W, Malm G, et al. European Multicentre Study on Congenital Toxoplasmosis. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics 2008; 121: E1215-22.
25. Roizen N, Kasza K, Karrison T, Mets M, Noble AG, Boyer K, et al. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: Implications for compensatory intervention strategies. Pediatrics 2006; 118: E379-90. (Pubitemid 46090508)
26. Bessiéres M H, Berrebi A, Rolland M, Bloom MC, Roques C, Cassaing S, et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol 2001; 94: 37-45. (Pubitemid 32007997)
27. Meroni V, Genco F, Tinelli C, Lanzarini P, Bollani L, Stronati M, et al. Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T gondiispecific immunoglobulin G antibodies. Clin Vaccine Immunol 2009; 16: 1517-20.
28. Avanzini MA, Maccario R, Belloni C, Carrera G, Bertaina A, Cagliuso M, et al. B lymphocyte subsets and their functional activity in the early months of life. Int J Immunopathol Pharmacol 2010; 23: 247-54.
29. Pinon JM, Dumon H, Chemla C, Franck J, Petersen E, Lebech M, et al. Strategy for diagnosis of congenital toxoplasmosis: Evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001; 39: 2267-71. (Pubitemid 32531492)
30. Sensini A. Toxoplasma gondii infection in pregnancy: Opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect 2006; 12: 504-12. (Pubitemid 43740761)
31. Kim K, Weiss LM. Toxoplasma gondii: The model apicomplexan. Int J Parasitol 2004; 34: 423-32. (Pubitemid 38299191)
32. Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D. Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev 2010; 23: 795-836.
33. Ibrahim HM, Huang P, Salem TA, Talaat RM, Nasr MI, Xuan X, et al. Short report: Prevalence of Neospora caninum and Toxoplasma gondii antibodies in northern Egypt. Am J Trop Med Hyg 2009; 80: 263-7.
34. Chahan B, Gaturaga I, Huang X, Liao M, Fukumoto S, Hirata H, et al. Serodiagnosis of Neospra caninum infection in cattle by enzymelinked immunosorbent assay with recombinant truncated NcSAG1. Vet Parasitol 2003; 118: 177-85.
35. Kang SW, Lee EH, Jean YH, Choe SE, Van Quyen D, Lee MS. The differential protein expression profiles and immunogenicity of tachyzoites and bradyzoites of in vitro cultured Neospora caninum. Parasitol Res 2008; 103: 905-13.
36. Wang CR, Zhai YQ, Zhao XC, Tan QJ, Chen J, Chen AH, et al. Preliminary application of PCR-based assay for the detection of Neospora caninum in bovine aborted fetus. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2009; 27: 140-3.
37. Edelhofer R, Loeschenberger K, Peschke R, Sager H, Nowotny N, Kolodziejek J, et al. First PCR-confirmed report of a Neospora caninum-associated bovine abortion in Austria. Vet Rec 2003; 152: 471-3. (Pubitemid 36512073)